MIC Capital Management (UK)’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$29.6M	Hold	9,644,032	–	–	8.4%	4
2025 Q4	$39.4M	Hold	9,644,032	–	–	8.94%	4
2025 Q3	$47.1M	Hold	9,644,032	–	–	9.41%	3
2025 Q2	$48.8M	Hold	9,644,032	–	–	9.58%	3
2025 Q1	$51M	Sell	9,644,032 -1	-0%	-$7	10.39%	3
2024 Q4	$65.2M	Buy	9,644,033 +1,192,275	+14%	+$8.02M	9.23%	3
2024 Q3	$55.7M	Hold	8,451,758	–	–	7.73%	4
2024 Q2	$63.4M	Hold	8,451,758	–	–	13.78%	2
2024 Q1	$84.3M	Hold	8,451,758	–	–	16%	2
2023 Q4	$83.3M	Hold	8,451,758	–	–	16.17%	2
2023 Q3	$64.7M	Hold	8,451,758	–	–	14.74%	2
2023 Q2	$63.1M	Hold	8,451,758	–	–	12.84%	2
2023 Q1	$56.4M	Hold	8,451,758	–	–	10.75%	2
2022 Q4	$65.2M	Hold	8,451,758	–	–	12.86%	2
2022 Q3	$89.9M	Hold	8,451,758	–	–	16.21%	2
2022 Q2	$68.8M	Buy	8,451,758 +7,062,869	+509%	+$47.3M	13.46%	2
2022 Q1	$9.94M	Hold	1,388,889	–	–	1.94%	15
2021 Q4	$23.8M	Buy	+1,388,889	New	+$26.1M	4.62%	9